市場調査レポート
商品コード
1067471

制酸剤の世界市場:2022~2026年

Global Antacids Market 2022-2026

出版日: | 発行: TechNavio | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
制酸剤の世界市場:2022~2026年
出版日: 2022年03月22日
発行: TechNavio
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の制酸剤の市場規模は、2022年から2026年の間に7億1,245万米ドルの成長が見込まれ、予測期間中のCAGRは3.37%となる見込みです。

この市場は、高齢者人口の増加、偏った生活習慣、非ステロイド性抗炎症薬(NSAIDs)の使用増加によって牽引されています。

当レポートでは、世界の制酸剤市場について調査分析し、市場規模、ファイブフォース分析、タイプ別市場セグメンテーション、顧客情勢、地域情勢、ベンダー分析に関する情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2021年
  • 市場の見通し:予測(2021~2026年)

第4章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第5章 市場セグメンテーション:タイプ別

  • 市場セグメント
  • 比較:タイプ別
  • 非対称型制酸剤:市場規模と予測(2021~2026年)
  • 対称型制酸剤:市場規模と予測(2021~2026年)
  • 市場機会:タイプ別

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域情勢

  • 地域セグメンテーション
  • 地域比較
  • 北米:市場規模と予測(2021~2026年)
  • 欧州:市場規模と予測(2021~2026年)
  • アジア:市場規模と予測(2021~2026年)
  • その他の地域(ROW):市場規模と予測(2021~2026年)
  • 米国:市場規模と予測(2021~2026年)
  • ドイツ:市場規模と予測(2021~2026年)
  • カナダ:市場規模と予測(2021~2026年)
  • 英国:市場規模と予測(2021~2026年)
  • ブラジル:市場規模と予測(2021~2026年)
  • 市場機会:地域情勢別

第8章 促進要因、課題、および動向

  • 市場の促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 革新の情勢
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • AmerisourceBergen Corp.
  • Bayer AG
  • Cardinal Health Inc.
  • GlaxoSmithKline Plc
  • Humco Holding Group Inc.
  • Johnson and Johnson
  • Novartis AG
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • WellSpring Pharmaceutical Corp.

第11章 付録

  • 調査範囲
  • 対象品目と除外品目のチェックリスト
  • 通貨換算レート(米ドル)
  • 調査手法
  • 略語のリスト
目次
Product Code: IRTNTR72909

Technavio has been monitoring the antacids market and it is poised to grow by $ 712.45 mn during 2022-2026 progressing at a CAGR of 3.37% during the forecast period. Our report on the antacids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population, poor lifestyle patterns, and increasing use of Non-steroidal anti-inflammatory drugs (NSAIDs).

The antacids market analysis includes the type segment and geographic landscape.

Technavio's antacids market is segmented as below:

By Type

  • Non-symmetric antacids
  • Symmetric antacids

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the growing e-commerce market as one of the prime reasons driving the antacids market growth during the next few years. Also, increasing awareness of GERD and self-medication will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on antacids market covers the following areas:

  • Antacids market sizing
  • Antacids market forecast
  • Antacids market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antacids market vendors that include Advance Pharmaceutical Inc., AmerisourceBergen Corp., Bayer AG, Cardinal Health Inc., GlaxoSmithKline Plc, Humco Holding Group Inc., iNova Pharmaceuticals, Johnson and Johnson, Neogen Corp., Novartis AG, NuCare Laboratories India, Pfizer Inc., Pharmaceutical Associates Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., United Natural Foods Inc., WellSpring Pharmaceutical Corp., and The Procter and Gamble Co. Also, the antacids market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
  • 5.3 Non-symmetric antacids - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
  • 5.4 Symmetric antacids - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Type
  • Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 Canada - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 Brazil - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 AmerisourceBergen Corp.
  • Exhibit 85: AmerisourceBergen Corp. - Overview
  • Exhibit 86: AmerisourceBergen Corp. - Business segments
  • Exhibit 87: AmerisourceBergen Corp. - Key offerings
  • Exhibit 88: AmerisourceBergen Corp. - Segment focus
  • 10.4 Bayer AG
  • Exhibit 89: Bayer AG - Overview
  • Exhibit 90: Bayer AG - Business segments
  • Exhibit 91: Bayer AG - Key offerings
  • Exhibit 92: Bayer AG - Segment focus
  • 10.5 Cardinal Health Inc.
  • Exhibit 93: Cardinal Health Inc. - Overview
  • Exhibit 94: Cardinal Health Inc. - Business segments
  • Exhibit 95: Cardinal Health Inc. - Key news
  • Exhibit 96: Cardinal Health Inc. - Key offerings
  • Exhibit 97: Cardinal Health Inc. - Segment focus
  • 10.6 GlaxoSmithKline Plc
  • Exhibit 98: GlaxoSmithKline Plc - Overview
  • Exhibit 99: GlaxoSmithKline Plc - Business segments
  • Exhibit 100: GlaxoSmithKline Plc - Key news
  • Exhibit 101: GlaxoSmithKline Plc - Key offerings
  • Exhibit 102: GlaxoSmithKline Plc - Segment focus
  • 10.7 Humco Holding Group Inc.
  • Exhibit 103: Humco Holding Group Inc. - Overview
  • Exhibit 104: Humco Holding Group Inc. - Product / Service
  • Exhibit 105: Humco Holding Group Inc. - Key offerings
  • 10.8 Johnson and Johnson
  • Exhibit 106: Johnson and Johnson - Overview
  • Exhibit 107: Johnson and Johnson - Business segments
  • Exhibit 108: Johnson and Johnson - Key news
  • Exhibit 109: Johnson and Johnson - Key offerings
  • Exhibit 110: Johnson and Johnson - Segment focus
  • 10.9 Novartis AG
  • Exhibit 111: Novartis AG - Overview
  • Exhibit 112: Novartis AG - Business segments
  • Exhibit 113: Novartis AG - Key offerings
  • Exhibit 114: Novartis AG - Segment focus
  • 10.10 Sanofi SA
  • Exhibit 115: Sanofi SA - Overview
  • Exhibit 116: Sanofi SA - Business segments
  • Exhibit 117: Sanofi SA - Key news
  • Exhibit 118: Sanofi SA - Key offerings
  • Exhibit 119: Sanofi SA - Segment focus
  • 10.11 Sun Pharmaceutical Industries Ltd.
  • Exhibit 120: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 121: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 122: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 10.12 WellSpring Pharmaceutical Corp.
  • Exhibit 123: WellSpring Pharmaceutical Corp. - Overview
  • Exhibit 124: WellSpring Pharmaceutical Corp. - Product / Service
  • Exhibit 125: WellSpring Pharmaceutical Corp. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Type
  • Exhibits27: Data Table on Comparison by Type
  • Exhibits28: Chart on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Non-symmetric antacids - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Non-symmetric antacids - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Symmetric antacids - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Symmetric antacids - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Symmetric antacids - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Type ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Brazil - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Brazil - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Brazil - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Brazil - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: AmerisourceBergen Corp. - Overview
  • Exhibits86: AmerisourceBergen Corp. - Business segments
  • Exhibits87: AmerisourceBergen Corp. - Key offerings
  • Exhibits88: AmerisourceBergen Corp. - Segment focus
  • Exhibits89: Bayer AG - Overview
  • Exhibits90: Bayer AG - Business segments
  • Exhibits91: Bayer AG - Key offerings
  • Exhibits92: Bayer AG - Segment focus
  • Exhibits93: Cardinal Health Inc. - Overview
  • Exhibits94: Cardinal Health Inc. - Business segments
  • Exhibits95: Cardinal Health Inc. - Key news
  • Exhibits96: Cardinal Health Inc. - Key offerings
  • Exhibits97: Cardinal Health Inc. - Segment focus
  • Exhibits98: GlaxoSmithKline Plc - Overview
  • Exhibits99: GlaxoSmithKline Plc - Business segments
  • Exhibits100: GlaxoSmithKline Plc - Key news
  • Exhibits101: GlaxoSmithKline Plc - Key offerings
  • Exhibits102: GlaxoSmithKline Plc - Segment focus
  • Exhibits103: Humco Holding Group Inc. - Overview
  • Exhibits104: Humco Holding Group Inc. - Product / Service
  • Exhibits105: Humco Holding Group Inc. - Key offerings
  • Exhibits106: Johnson and Johnson - Overview
  • Exhibits107: Johnson and Johnson - Business segments
  • Exhibits108: Johnson and Johnson - Key news
  • Exhibits109: Johnson and Johnson - Key offerings
  • Exhibits110: Johnson and Johnson - Segment focus
  • Exhibits111: Novartis AG - Overview
  • Exhibits112: Novartis AG - Business segments
  • Exhibits113: Novartis AG - Key offerings
  • Exhibits114: Novartis AG - Segment focus
  • Exhibits115: Sanofi SA - Overview
  • Exhibits116: Sanofi SA - Business segments
  • Exhibits117: Sanofi SA - Key news
  • Exhibits118: Sanofi SA - Key offerings
  • Exhibits119: Sanofi SA - Segment focus
  • Exhibits120: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits121: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits122: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits123: WellSpring Pharmaceutical Corp. - Overview
  • Exhibits124: WellSpring Pharmaceutical Corp. - Product / Service
  • Exhibits125: WellSpring Pharmaceutical Corp. - Key offerings
  • Exhibits126: Inclusions checklist
  • Exhibits127: Exclusions checklist
  • Exhibits128: Currency conversion rates for US$
  • Exhibits129: Research methodology
  • Exhibits130: Validation techniques employed for market sizing
  • Exhibits131: Information sources
  • Exhibits132: List of abbreviations